Pharmadax Inc (法德生技藥品) yesterday said it has gained marketing approval in China for its generic schizophrenia drug and expects to grab 20 percent of the market within three years.
On Sunday, the company received approval from the Chinese National Medical Products Administration (NMPA) for the 50mg, 150mg, 200mg, 300mg and 400mg versions of its quetiapine fumarate ER tablets, Pharmadax said, adding that its drug is the generic version of AstraZeneca PLC’s Seroquel XR tablet.
The company obtained US Food and Drug Administration (FDA) approval for the antipsychotic drug in 2017.
The US approval helped the firm secure a priority review with the NMPA, which sped up the licensing process to less than two years, Pharmadax said.
While competition has become heated in the US, with a few companies producing generic versions of Seroquel, including Handa Pharmaceuticals Inc (漢達生技) and India’s Lupin Ltd, Pharmadax said that there would be less competition in China.
“Currently, only the original Seroquel is available in China, and we are the first generic drug company to obtain approval, while other companies are still waiting, so we are confident that we can stay ahead of our rivals,” a company official told the Taipei Times.
Sales of quetiapine fumarate tablets in China increased 32.13 percent year-on-year to 1.75 billion yuan (US$244.9 million) last year, Pharmadax said.
With the Chinese government paying more attention to mental health, more health programs or support services are expected to be launched in the country, which would likely boost sales of antipsychotic drugs, the company said.
Pharmadax has set a target of annual sales growth of 50 percent over the next three years, aided by China-based Coland Holdings Ltd (康聯控股), which is responsible for marketing the drug for the next five years.
Coland has set up distribution channels in more than 200 cities and at more than 3,500 hospitals in China, Pharmadax said.
The company said it would begin marketing the drug in China soon, declining to give an exact date.
Pharmadax has finalized the prices for Quetiapine Fumarate with Coland, which would be slightly lower than the original drug, it said.
The company would produce 800 million tablets per year at its two plants in Foshan, Guangdong Province, it added.
TECH BOOST: New TSMC wafer fabs in Arizona are to dramatically improve US advanced chip production, a report by market research firm TrendForce said With Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) pouring large funds into Arizona, the US is expected to see an improvement in its status to become the second-largest maker of advanced semiconductors in 2027, Taipei-based market researcher TrendForce Corp (集邦科技) said in a report last week. TrendForce estimates the US would account for a 21 percent share in the global advanced integrated circuit (IC) production market by 2027, sharply up from the current 9 percent, as TSMC is investing US$65 billion to build three wafer fabs in Arizona, the report said. TrendForce defined the advanced chipmaking processes as the 7-nanometer process or more
China’s Huawei Technologies Co (華為) plans to start mass-producing its most advanced artificial intelligence (AI) chip in the first quarter of next year, even as it struggles to make enough chips due to US restrictions, two people familiar with the matter said. The telecoms conglomerate has sent samples of the Ascend 910C — its newest chip, meant to rival those made by US chipmaker Nvidia Corp — to some technology firms and started taking orders, the sources told Reuters. The 910C is being made by top Chinese contract chipmaker Semiconductor Manufacturing International Corp (SMIC, 中芯) on its N+2 process, but a lack
NVIDIA PLATFORM: Hon Hai’s Mexican facility is to begin production early next year and a Taiwan site is to enter production next month, Nvidia wrote on its blog Hon Hai Precision Industry Co (鴻海精密), the world’s biggest electronics manufacturer, yesterday said it is expanding production capacity of artificial intelligence (AI) servers based on Nvidia Corp’s Blackwell chips in Taiwan, the US and Mexico to cope with rising demand. Hon Hai’s new AI-enabled factories are to use Nvidia’s Omnivores platform to create 3D digital twins to plan and simulate automated production lines at a factory in Hsinchu, the company said in a statement. Nvidia’s Omnivores platform is for developing industrial AI simulation applications and helps bring facilities online faster. Hon Hai’s Mexican facility is to begin production early next year and the
Who would not want a social media audience that grows without new content? During the three years she paused production of her short do-it-yourself (DIY) farmer’s lifestyle videos, Chinese vlogger Li Ziqi (李子柒), 34, has seen her YouTube subscribers increase to 20.2 million from about 14 million. While YouTube is banned in China, her fan base there — although not the size of YouTube’s MrBeast, who has 330 million subscribers — is close to 100 million across the country’s social media platforms Douyin (抖音), Sina Weibo (新浪微博) and Xiaohongshu (小紅書). When Li finally released new videos last week — ending what has
RSS